Certified by Founder Lodge 
                                        
                                        PJC
 
                                                 United States  -  Boston, MA 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $17,000,000
                                            12 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            PJC is an early-stage venture capital firm focused on investing in, supporting, and building relationships with entrepreneurs who are creating the future. The firm seeks to be the first insti
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   VisuWell | 
                                                            February, 10 ,2022 | Series B | $10,000,000 | 
   Synthesis AI | 
                                                            April, 28 ,2022 | Series A | $17,000,000 | 
   Diligent Pharma | 
                                                            May, 16 ,2023 | Series A | $8,270,000 | 
   Thunkable | 
                                                            April, 05 ,2022 | Series B | $30,000,000 | 
   Grapevine | 
                                                            August, 09 ,2023 | Seed | $1,850,000 | 
   VisuWell | 
                                                            February, 10 ,2022 | Series B | $10,000,000 | 
   AceUp | 
                                                            September, 13 ,2024 | Series A | $22,500,000 | 
   Diligent Pharma | 
                                                            May, 16 ,2023 | Series A | $8,270,000 | 
   Cohora | 
                                                            September, 13 ,2024 | Unknown | $2,500,000 | 
   Grapevine | 
                                                            August, 09 ,2023 | Seed | $1,850,000 | 
   AceUp | 
                                                            September, 13 ,2024 | Series A | $22,500,000 | 
   Cohora | 
                                                            September, 13 ,2024 | Unknown | $2,500,000 | 
                                                
  VisuWell
  Synthesis AI
  Diligent Pharma
  Thunkable
  Grapevine
  AceUp
  Cohora
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)